Using the same AKT gene module as before, we estimated activity scores for 39 breast cancer cell lines (Affymetrix gene expression data), which were then correlated to − log10IC50 values for 140 drugs, including rapamycin and 10 other AKT/PI3K/mTOR inhibitors. Here, AKT1 is linked to breast carcinoma.